MEDTECH CAPITAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDTECH CAPITAL
Largest movements
- Receivables within one year -€19,627
no longer reported in 2025 (was €19,627)
- Profit (loss) carried forward -€29,805
down €29,805 (-60.8%), from -€48,982 to -€78,787
- Other debts +€8,653
up €8,653 (+162%), from €5,350 to €14,003
- Accrued charges and deferred income +€1,666
up €1,666 (+632%), from €264 to €1,930
- Tax, wage and social debts -€1,076
down €1,076 (-25.0%), from €4,304 to €3,228
- Trade debts +€936
up €936 (+2.0%), from €47,156 to €48,092
- Gross operating margin -€22,948
down €22,948 (-379%), from -€6,049 to -€28,997
- Other operating charges -€4,326
down €4,326 (-84.4%), from €5,127 to €801
- Financial charges -€4,093
down €4,093 (-99.8%), from €4,100 to €8
- Financial income -€868
no longer reported in 2025 (was €868)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €20,491 | €865 | -€19,626 | -95.8% |
| Current assets | 29/58 | €20,491 | €865 | -€19,626 | -95.8% |
| Amounts receivable within one year | 40/41 | €19,627 | - | -€19,627 | |
| Other amounts receivable | 41 | €19,627 | - | -€19,627 | |
| Cash at bank and in hand | 54/58 | - | €1 | +€1 | |
| Deferred charges and accrued income | 490/1 | €864 | €864 | = | 0.0% |
| Total equity and liabilities | 10/49 | €20,491 | €865 | -€19,626 | -95.8% |
| Equity | 10/15 | -€36,582 | -€66,387 | -€29,805 | -81.5% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€48,982 | -€78,787 | -€29,805 | -60.8% |
| Amounts payable | 17/49 | €57,073 | €67,252 | +€10,179 | +17.8% |
| Amounts payable within one year | 42/48 | €56,809 | €65,322 | +€8,513 | +15.0% |
| Trade debts | 44 | €47,156 | €48,092 | +€936 | +2.0% |
| Suppliers | 440/4 | €47,156 | €48,092 | +€936 | +2.0% |
| Taxes, remuneration and social security | 45 | €4,304 | €3,228 | -€1,076 | -25.0% |
| Taxes | 450/3 | €4,304 | €3,228 | -€1,076 | -25.0% |
| Other amounts payable | 47/48 | €5,350 | €14,003 | +€8,653 | +162% |
| Accrued charges and deferred income | 492/3 | €264 | €1,930 | +€1,666 | +632% |
| Other operating charges | 640/8 | €5,127 | €801 | -€4,326 | -84.4% |
| Gross operating margin | 9900 | -€6,049 | -€28,997 | -€22,948 | -379% |
| Operating profit (loss) | 9901 | -€11,176 | -€29,798 | -€18,622 | -167% |
| Financial income | 75/76B | €868 | - | -€868 | |
| Recurring financial income | 75 | €868 | - | -€868 | |
| Financial charges | 65/66B | €4,100 | €8 | -€4,093 | -99.8% |
| Recurring financial charges | 65 | €4,100 | €8 | -€4,093 | -99.8% |
| Profit (loss) for the period before taxes | 9903 | -€14,408 | -€29,805 | -€15,397 | -107% |
| Profit (loss) for the period | 9904 | -€14,408 | -€29,805 | -€15,397 | -107% |
| Profit (loss) for the period to be appropriated | 9905 | -€14,408 | -€29,805 | -€15,397 | -107% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.